Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

NHS National Proprietary Pharmaceuticals - Low Molecular Weight Heparins and Fondaparinux Products

NHS England

This public procurement record has 4 releases in its history.

Award

18 Dec 2025 at 11:34

UK7 - Contract Details Notice
Award

28 Nov 2025 at 12:41

UK6 - Contract Award Notice
Tender

19 Sep 2025 at 09:52

UK4 - Tender Notice
Planning

07 Aug 2025 at 15:21

UK2 - Preliminary Market Engagement Notice
Summary of the contracting process

NHS England has concluded the procurement process for a framework agreement concerning NHS National Proprietary Pharmaceuticals, specifically targeting Low Molecular Weight Heparins and Fondaparinux products. The agreement is set to commence on 1st March 2026 and will run until 29th February 2028, with an optional extension of up to 24 months available at the authority's discretion. The procurement was conducted using an open procedure, under the legal basis of the UK's 2023/54 legislative framework, and is classified under the pharmaceutical industry. The contracting process embraces numerous delivery regions across the United Kingdom, including UKC, UKD, UKF, UKG, UKH, UKI, UKJ, UKK, and UKE. The procurement stage is complete, with the contract signing date recorded as 11th December 2025, and a total contract value reaching £385.6 million (£321.3 million net of VAT).

This tender presents significant growth opportunities for businesses engaged in the pharmaceutical supply chain, particularly those specialising in the production and distribution of generic or proprietary pharmaceuticals. The framework agreement's structure allows for the participation of both large-scale enterprises and small to medium-sized enterprises (SMEs), providing a comprehensive platform for market engagement. Companies like Aventis Pharma Ltd, Northumbria Pharma Ltd, and Pfizer Ltd are among the recognised suppliers, signalling the competitive nature and significant calibre of participants involved. With the UK geographical spread and substantial financial scope, this procurement process offers potential suppliers a robust foundation for business expansion and increased market influence within the NHS framework across the region.

How relevant is this notice?

Notice Information

Notice Title

NHS National Proprietary Pharmaceuticals - Low Molecular Weight Heparins and Fondaparinux Products

Notice Description

NHS National Proprietary Pharmaceuticals - Low Molecular Weight Heparins and Fondaparinux Products - CM/PHR/25/5732 Period of Framework Agreement: 1 March 2026 to 29 February 2028 with an option or option(s) to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

Lot Information

Lot 1

Options: With an option or options to extend upto 24 months at the Authority's Discretion

Renewal: With an option or option(s) to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

Planning Information

NHS England is advising suppliers of an upcoming tender for the NHS National Framework Agreement for the supply of Low Molecular Weight Heparins and Fondaparinux to commence 1st March 2026 for 24 months with the option to extend for a further 24 months. The purpose of this notice is to inform existing and potential new suppliers that if NHS England believe that it would be beneficial a virtual 1:1 preliminary market meeting can be arranged. Please contact ian.birch1@nhs.net to register your interest. There will also be a 7 day window for queries to be raised via Atamis after all sessions have concluded.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-05838e
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/084259-2025
Current Stage
Award
All Stages
Planning, Tender, Award

Procurement Classification

Notice Type
UK7 - Contract Details Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
SME
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£176,000,000 £100M-£1B
Lots Value
£176,000,000 £100M-£1B
Awards Value
£321,349,256 £100M-£1B
Contracts Value
£321,349,256 £100M-£1B

Notice Dates

Publication Date
18 Dec 20258 months ago
Submission Deadline
22 Oct 2025Expired
Future Notice Date
19 Sep 2025Expired
Award Date
28 Nov 20259 months ago
Contract Period
1 Mar 2026 - 29 Feb 2028 2-3 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Active, Pending
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LONDON
Postcode
SE1 8UG
Postcode Area
South East London
Country
England
Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI4 Inner London - East
Small Region (ITL 3)
TLI45 Lambeth
Delivery Location
TLC North East (England), TLD North West (England), TLE Yorkshire and The Humber, TLF East Midlands (England), TLG West Midlands (England), TLH East (England), TLI London, TLJ South East (England), TLK South West (England)
Local Authority
Lambeth
Electoral Ward
Waterloo & South Bank
Westminster Constituency
Vauxhall and Camberwell Green

Supplier Information

Number of Suppliers
13
Supplier Names

Aventis Pharma Ltd t-a Sanofi

Aventis Pharma ltd t/a Sanofi

Kent Pharma UK Limited

Northumbria Pharma Limited

Northumbria Pharma Ltd

Pfizer Limited

Pfizer Ltd

ROVI Biotech Ltd

Rovi Biotech Limited

Techdow Pharma England Limited

Techdow Pharma England Ltd

Venipharm Ltd

Viatris UK Healthcare Limited

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...